Kenneth R Pitzer is SVP, PROD STRAT & COMM PLNG of Theravance Biopharma, Inc.. Currently has a direct ownership of 380,123 shares of TBPH, which is worth approximately $3.13 Million. The most recent transaction as insider was on Feb 18, 2022, when has been sold 27,299 shares (Ordinary Shares) at a price of $9.61 per share, resulting in proceeds of $262,343. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 380K
0% 3M change
0% 12M change
Total Value Held $3.13 Million

KENNETH R PITZER Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 18 2022
SELL
Payment of exercise price or tax liability
$262,343 $9.61 p/Share
27,299 Reduced 6.7%
380,123 Ordinary Shares
Feb 07 2022
BUY
Grant, award, or other acquisition
-
52,000 Added 11.32%
407,422 Ordinary Shares
Nov 19 2021
SELL
Payment of exercise price or tax liability
$36,032 $8.36 p/Share
4,310 Reduced 1.2%
355,422 Ordinary Shares
Aug 20 2021
SELL
Payment of exercise price or tax liability
$60,513 $14.05 p/Share
4,307 Reduced 1.18%
359,732 Ordinary Shares
May 20 2021
SELL
Payment of exercise price or tax liability
$76,718 $17.8 p/Share
4,310 Reduced 1.17%
364,039 Ordinary Shares
Feb 20 2021
SELL
Payment of exercise price or tax liability
$599,984 $18.79 p/Share
31,931 Reduced 7.98%
368,349 Ordinary Shares
Feb 08 2021
BUY
Grant, award, or other acquisition
-
65,000 Added 13.97%
400,280 Ordinary Shares
Nov 20 2020
SELL
Payment of exercise price or tax liability
$82,728 $17.21 p/Share
4,807 Reduced 1.41%
335,280 Ordinary Shares
KRP

Kenneth R Pitzer

SVP, PROD STRAT & COMM PLNG
South San Francisco, CA

Track Institutional and Insider Activities on TBPH

Follow Theravance Biopharma, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TBPH shares.

Notify only if

Insider Trading

Get notified when an Theravance Biopharma, Inc. insider buys or sells TBPH shares.

Notify only if

News

Receive news related to Theravance Biopharma, Inc.

Track Activities on TBPH